DK1651270T3 - Medikamenter til inhalation omfattende betamimetika og et anticholinergikum - Google Patents

Medikamenter til inhalation omfattende betamimetika og et anticholinergikum

Info

Publication number: DK1651270T3
Authority: DK; Denmark
Prior art keywords: anticholinergic; betamimetics; medications; inhalation; agonists
Prior art date: 2003-07-29

Application number

DK04741130T

Other languages

English (en)

Inventor

Christopher John Montagu Meade

Michel Pairet

Michael P Pieper

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-29

Filing date

2004-07-17

Publication date

2007-07-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34130039&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1651270(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-07-17 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2007-07-16 Application granted granted Critical

2007-07-16 Publication of DK1651270T3 publication Critical patent/DK1651270T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK04741130T 2003-07-29 2004-07-17 Medikamenter til inhalation omfattende betamimetika og et anticholinergikum DK1651270T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03017163		2003-07-29
PCT/EP2004/008030 WO2005014044A1 (en)	2003-07-29	2004-07-17	Medicaments for inhalation comprising betamimetics and an anticholinergic

Publications (1)

Publication Number	Publication Date
DK1651270T3 true DK1651270T3 (da)	2007-07-16

Family

ID=34130039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04741130T DK1651270T3 (da)	2003-07-29	2004-07-17	Medikamenter til inhalation omfattende betamimetika og et anticholinergikum

Country Status (21)

Country	Link
EP (2)	EP1803469A3 (da)
JP (1)	JP2007500151A (da)
KR (1)	KR20060052911A (da)
CN (1)	CN1829534A (da)
AT (1)	ATE357258T1 (da)
AU (1)	AU2004262902B2 (da)
BR (1)	BRPI0413129A (da)
CA (1)	CA2534132C (da)
CY (1)	CY1106430T1 (da)
DE (1)	DE602004005462T2 (da)
DK (1)	DK1651270T3 (da)
ES (1)	ES2284025T3 (da)
IL (1)	IL173371A0 (da)
MX (1)	MXPA06001047A (da)
NZ (1)	NZ545442A (da)
PL (1)	PL1651270T3 (da)
PT (1)	PT1651270E (da)
RU (1)	RU2375059C2 (da)
SI (1)	SI1651270T1 (da)
WO (1)	WO2005014044A1 (da)
ZA (1)	ZA200600372B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
US20070179181A1 (en) *	2004-03-17	2007-08-02	Baxter Andrew D	Treatment of inflammatory disorders and pain using beta-aminoalcohols
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2257152B1 (es) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
CN101208316B (zh)	2005-08-15	2012-05-09	贝林格尔·英格海姆国际有限公司	制备β-模拟物的方法
JP2010519195A (ja)	2007-02-19	2010-06-03	シプラ・リミテッド	薬学的組成物
EP2100598A1 (en) *	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) *	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
TWI792140B (zh)	2009-05-29	2023-02-11	美商沛爾醫療股份有限公司	用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
EP2666465A1 (en) *	2012-05-25	2013-11-27	Almirall, S.A.	Novel dosage and formulation
RU2510267C2 (ru) *	2012-06-15	2014-03-27	Шолекс Девелопмент Гмбх	Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
SG11201507286QA (en)	2013-03-15	2015-10-29	Pearl Therapeutics Inc	Methods and systems for conditioning of particulate crystalline materials
CZ2014188A3 (cs)	2014-03-26	2015-10-07	Zentiva, K.S.	Nové formy aclidinium chloridu a způsob jejich přípravy
PT108370B (pt) *	2015-03-30	2018-10-25	Hovione Farm S A	Processo de preparação de brometo de aclidínio

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
AT396872B (de)	1985-07-30	1993-12-27	Glaxo Group Ltd	Gerät zur verabreichung von medikamenten in pulverform
SE453566B (sv)	1986-03-07	1988-02-15	Draco Ab	Anordning vid pulverinhalatorer
US5290815A (en) *	1989-09-07	1994-03-01	Glaxo Group Limited	Treatment of inflammation and allergy
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
IL107120A (en)	1992-09-29	1997-09-30	Boehringer Ingelheim Int	Atomising nozzle and filter and spray generating device
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
DE19536903C2 (de)	1995-10-04	1998-09-10	Boehringer Ingelheim Int	Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de)	1995-12-05	1997-06-19	Boehringer Ingelheim Int	Sperrspannwerk für einen federbetätigten Abtrieb
DE19847968A1 (de)	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
GB9913083D0 (en) *	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0012261D0 (en) *	2000-05-19	2000-07-12	Astrazeneca Ab	Novel process
BR0015884A (pt) *	2000-05-22	2003-07-08	Chiesi Farma Spa	Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
DE10050994A1 (de) *	2000-10-14	2002-04-18	Boehringer Ingelheim Pharma	Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
GB0103630D0 (en) *	2001-02-14	2001-03-28	Glaxo Group Ltd	Chemical compounds
CA2459493C (en) *	2001-09-14	2011-08-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New pharmaceutical compositions for inhalation
WO2003042160A1 (en) *	2001-11-13	2003-05-22	Theravance, Inc.	Aryl aniline beta-2 adrenergic receptor agonists
DE10216333A1 (de) *	2002-04-13	2003-10-30	Boehringer Ingelheim Pharma	Neue Carbonsäureester mit anticholonerger Wirksamkeit, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

2004
- 2004-07-17 PT PT04741130T patent/PT1651270E/pt unknown
- 2004-07-17 EP EP06122278A patent/EP1803469A3/en not_active Withdrawn
- 2004-07-17 KR KR1020067001861A patent/KR20060052911A/ko not_active Ceased
- 2004-07-17 BR BRPI0413129-0A patent/BRPI0413129A/pt not_active IP Right Cessation
- 2004-07-17 EP EP04741130A patent/EP1651270B1/en not_active Revoked
- 2004-07-17 ES ES04741130T patent/ES2284025T3/es not_active Expired - Lifetime
- 2004-07-17 CN CNA2004800220928A patent/CN1829534A/zh active Pending
- 2004-07-17 DE DE602004005462T patent/DE602004005462T2/de not_active Expired - Lifetime
- 2004-07-17 WO PCT/EP2004/008030 patent/WO2005014044A1/en not_active Ceased
- 2004-07-17 AT AT04741130T patent/ATE357258T1/de active
- 2004-07-17 JP JP2006521461A patent/JP2007500151A/ja not_active Withdrawn
- 2004-07-17 MX MXPA06001047A patent/MXPA06001047A/es active IP Right Grant
- 2004-07-17 PL PL04741130T patent/PL1651270T3/pl unknown
- 2004-07-17 AU AU2004262902A patent/AU2004262902B2/en not_active Revoked
- 2004-07-17 DK DK04741130T patent/DK1651270T3/da active
- 2004-07-17 NZ NZ545442A patent/NZ545442A/en not_active IP Right Cessation
- 2004-07-17 SI SI200430315T patent/SI1651270T1/sl unknown
- 2004-07-17 RU RU2006105713/15A patent/RU2375059C2/ru not_active IP Right Cessation
- 2004-07-17 CA CA2534132A patent/CA2534132C/en not_active Expired - Lifetime
2006
- 2006-01-13 ZA ZA2006/00372A patent/ZA200600372B/en unknown
- 2006-01-26 IL IL173371A patent/IL173371A0/en unknown
2007
- 2007-04-02 CY CY20071100456T patent/CY1106430T1/el unknown

Also Published As

Publication number	Publication date
CY1106430T1 (el)	2011-10-12
CA2534132A1 (en)	2005-02-17
ATE357258T1 (de)	2007-04-15
CN1829534A (zh)	2006-09-06
JP2007500151A (ja)	2007-01-11
DE602004005462T2 (de)	2007-07-05
PT1651270E (pt)	2007-04-30
ZA200600372B (en)	2006-12-27
AU2004262902A1 (en)	2005-02-17
ES2284025T3 (es)	2007-11-01
EP1803469A2 (en)	2007-07-04
KR20060052911A (ko)	2006-05-19
PL1651270T3 (pl)	2007-06-29
NZ545442A (en)	2010-05-28
MXPA06001047A (es)	2006-04-24
WO2005014044A1 (en)	2005-02-17
EP1803469A3 (en)	2011-10-26
SI1651270T1 (sl)	2007-08-31
DE602004005462D1 (de)	2007-05-03
AU2004262902B2 (en)	2009-07-30
RU2006105713A (ru)	2007-09-10
CA2534132C (en)	2013-11-26
EP1651270A1 (en)	2006-05-03
RU2375059C2 (ru)	2009-12-10
BRPI0413129A (pt)	2006-10-03
EP1651270B1 (en)	2007-03-21
IL173371A0 (en)	2006-06-11

Publication	Publication Date	Title
DK1651270T3 (da)	2007-07-16	Medikamenter til inhalation omfattende betamimetika og et anticholinergikum
DK1408967T3 (da)	2010-03-08	Lægemiddelsammensætninger på basis af tiotropium, ciclesonide og et betamimetikum til behandling af inflammatoriske eller obstruktive luftvejssygdomme
UY27755A1 (es)	2003-11-28	Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
SE0301700D0 (sv)	2003-06-10	Novel compounds
DE60220887D1 (de)	2007-08-09	Agonisten von beta-adrenorezeptoren
SG167657A1 (en)	2011-01-28	Novel medicament compositions based on tiotropium salts and on salmeterol salts
NO20044107L (no)	2004-11-04	Medikamenter inneholdende betamimetica og et nytt anticholinergisk legemiddel
CY1110373T1 (el)	2015-04-29	Συνεργιστικος συνδυασμος που περιλαμβανει ροφλουμιλαστη και εναν αντιχολινεργικο παραγοντα που επιλεγεται απο αλατα τιοτροπιου για την θεραπεια αναπνευστικων ασθενειων
MX2007003031A (es)	2007-05-23	Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
EA200601837A1 (ru)	2007-04-27	Бензоксазины для лечения заболеваний дыхательных путей
DK1545537T3 (da)	2007-07-02	Alfa-7-nikotinreceptoragonister og statiner i kombination
UY27759A1 (es)	2003-11-28	Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
ATE526967T1 (de)	2011-10-15	Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
TW200640911A (en)	2006-12-01	Novel, long acting betamimetics for the treatment of respiratory diseases
ATE420641T1 (de)	2009-01-15	Medikamente zur inhalation mit betamimetika und einem anticholinergikum
MY146802A (en)	2012-09-28	Novel drugs for treating respiratory diseases
DE60310730D1 (de)	2007-02-08	Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
SE0103210D0 (sv)	2001-09-27	New formulations and use thereof
DK1523985T3 (da)	2010-05-31	Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
DE50115277D1 (de)	2010-02-04	Arzneimittelkompositionen aus tiotropiumsalzen und
DE60321954D1 (de)	2008-08-14	Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol
DE502006004194D1 (de)	2009-08-20	Homogemcitabine
MXPA03005585A (es)	2004-05-05	Nuevas composiciones de medicamentos a base de anticolinergicos y agonistas de dopamina.
SG163512A1 (en)	2010-08-30	Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion